Centro Médico Teknon
Barcelona, 08022, Spain
NCT Number: NCT04437589
Cranio-cervical instability (CCI) has been well identified in diseases regarding connective tissue, such as Ehlers-Danlos Syndrome/Hipermobility Type (EDS-HT). These patients frequently suffer from severe widespread pain with very difficult management and control. Chronic neuroinflamation, opioid-induced hyperalgesia, and central sensitization phenomena may explain this complex painful condition. A retrospective, observational, consecutive case series study is designed to determine if opioid-free anesthetic management shows a reduction in postoperative pain and opioid rescues needs in comparison with opioid-based anesthesia management for patients with EDS-HT undergoing crano-cervical fixation.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Observational
Barcelona, 08022, Spain
Cranio-cervical instability (CCI) has been well identified in diseases regarding connective tissue, such as Ehlers-Danlos Syndrome/Hipermobility Type (EDS-HT). These patients frequently suffer from severe widespread pain with very difficult management and control. Chronic neuroinflamation, opioid-induced hyperalgesia, and central sensitization phenomena may explain this complex painful condition. A retrospective, observational, consecutive case series study is designed to determine if opioid-free anesthetic management shows a reduction in postoperative pain and opioid rescues needs in comparison with opioid-based anesthesia management for patients with EDS-HT undergoing craneo-cervical fixation.
Main Aim: To determine if the administration of opioid-free anesthesia with propofol, lidocaine, ketamine, and dexmedetomidine shows reduction of postoperative pain, and postoperative needs of opioids rescue in patients undergoing CCF.
Secondary Aims:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline
Patient's age when the surgery was performed (in years)
Time frame: Baseline
Patient sex classified in two groups: female (1) and male (2)
Time frame: Baseline
Postoperative analgesia is a nominal variable which indicates the type of analgesia administered to the patient.
There are 4 options: Lidocaine-Ketamine-Dexmetodimine (LKDi) as group 1, PCA morphine infusion pump as group 2, Ketamine perfusion as group 3 and Methadone-Ketamine as group 4.
Time frame: Baseline
Escala Visual Analógica de dolor (EVA) is an analogic visual scale to measure the patients pain. It has a range between 0 and 10. Higher values mean more pain.
The Preoperative EVA measures the pain before the surgery. If there is more than one measure the result is presented as the mean of all measurements.
Time frame: Baseline
The preoperative opioids is a categorical variable that indicates if the patient took opioids before the surgery.
There are 4 options:
Time frame: 1 day after surgery
Escala Visual Analógica de dolor (EVA) is an analogic visual scale to measure the patients pain. It has a range between 0 and 10. Higher values mean more pain.
The postoperative EVA 1 is measured 1 day after surgery.
Time frame: 2 days after surgery
Escala Visual Analógica de dolor (EVA) is an analogic visual scale to measure the patients pain. It has a range between 0 and 10. Higher values mean more pain.
The postoperative EVA 2 is measured 2 day after surgery.
Time frame: 4 days after surgery
Escala Visual Analógica de dolor (EVA) is an analogic visual scale to measure the patients pain. It has a range between 0 and 10. Higher values mean more pain.
The postoperative EVA 4 is measured 4 day after surgery.
Time frame: 6 days after surgery
Escala Visual Analógica de dolor (EVA) is an analogic visual scale to measure the patients pain. It has a range between 0 and 10. Higher values mean more pain.
The postoperative EVA 6 is measured 6 day after surgery.
Time frame: From surgery release till first day of hospitalization
Number of pills of sufentanil that the patient has token besides the main treatment. The variable is gathered 1 day after surgery.
Sufentanil doses 1 is a categorical variable with 4 levels:
Time frame: From first day of hospitalization till second day of hospitalization
Number of pills of sufentanil that the patient has token besides the main treatment. The variable is 2 days after surgery.
Sufentanil doses 2 is a categorical variable with 4 levels:
Time frame: From second day of hospitalization till fourth day of hospitalization
Number of pills of sufentanil that the patient has token besides the main treatment. The variable is gathered 4 days after surgery.
Sufentanil doses 4 is a categorical variable with 4 levels:
Time frame: From fourth day of hospitalization till sixth day of hospitalization
Number of pills of sufentanil that the patient has token besides the main treatment. The variable is gathered 6 days after surgery.
Sufentanil doses 6 is a categorical variable with 4 levels:
Time frame: Baseline
Rescue Methadone is a categorical variable that indicates if the patient required the use of methadone as a secondary treatment besides the main one.
The variable has 4 levels:
Time frame: From surgery release till first day of hospitalization
For those cases in which an infusion PCA morphine pump was placed, mean dose 1 day after surgery of the administered morphine.
Daily morphine dosage is a categorical variable of 4 levels:
Time frame: From first day of hospitalization till second day of hospitalization
For those cases in which an infusion PCA morphine pump was placed, mean dose 2 days after surgery of the administered morphine.
Daily morphine dosage is a categorical variable of 4 levels:
Time frame: From second day of hospitalization till fourth day of hospitalization
For those cases in which an infusion PCA morphine pump was placed, mean dose 4 days after surgery of the administered morphine.
Daily morphine dosage is a categorical variable of 4 levels:
Time frame: From fourth day of hospitalization till sixth day of hospitalization
For those cases in which an infusion PCA morphine pump was placed, mean dose 6 days after surgery of the administered morphine.
Daily morphine dosage is a categorical variable of 4 levels:
Time frame: Baseline
Nausea and vomiting is a categorical variable that indicates if the patient reported having nausea or vomiting in the control postoperative visits. The variable has 2 states: Yes (1) or No (0).
Time frame: Baseline
Intestinal ileus is a categorical variable that indicates if the doctor or nurse reported an intestinal ileus when performing the postoperative control visit. The variable has 2 states: Yes (1) or No (0).
Time frame: Baseline
Constipation is a categorical variable that indicates if the patient reported having constipation in the control postoperative visits. The variable has 2 states: Yes (1) or No (0).
Time frame: Baseline
The Anxiolytic rescue agent is a categorical variable that indicates if there was a need of applying an axiolytic as a rescue agent besides the main postoperative treatment.
The variable has 5 levels:
Time frame: Baseline
Oral ketamine is a categorical variable that indicates if the patient required the use of oral ketamine besides the main postoperative treatment. The variable has 2 states: Yes (1) or No (0).
Time frame: Up to 6 days
The Chronic opioid and hospital discharge variable is a categorical variable that resumes the patient state when discharged from the hospital. The variable compares the preoperative opioid dosage with the postoperative dosage prescription.
The variable has 4 levels:
Servei Central d'Anestesiologia
Other
Opioid-Free Intravenous Anesthesia for Patients With Joint Hypermobility Syndrome Undergoing Craneo-Cervical Fixation: A Case-series Study Focused on Anti-hyperalgesic Approach
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05137379
Cardiovascular Diseases, Collagen Diseases
Paris, France
View Trial DetailsNCT06105541
Cardiovascular Diseases, Collagen Diseases
Charleston, South Carolina, United States
View Trial DetailsNCT03093493
Cardiovascular Diseases, Collagen Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT03681080
Autonomic Failure, Autonomic Nervous System Diseases
Aachen, North Rhine-Westphalia, Germany
View Trial Details